Clinical Pharmacokinetics of Hydrallazine
- 1 January 1977
- journal article
- research article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 2 (5), 317-329
- https://doi.org/10.2165/00003088-197702050-00001
Abstract
No abstract availableThis publication has 53 references indexed in Scilit:
- Spontaneous Systemic Lupus Erythematosus and Acetylator PhenotypeActa Medica Scandinavica, 1977
- Acetylator Phenotype in Patients with Hydralazine‐induced Lupoid SyndromeActa Medica Scandinavica, 1976
- 3-Hydroxymethyl-s-triazolo[3,4-a]phthalazine, a novel urinary hydralazine metabolite in manJournal of Medicinal Chemistry, 1975
- Elimination rate ofN-acetylprocainamide after a single intravenous dose of procainamide hydrochloride in manJournal of Pharmacokinetics and Biopharmaceutics, 1975
- THE EFFECT OF ALPRENOLOL IN COMBINATION WITH HYDRALAZINE IN ESSENTIAL HYPERTENSIONActa Medica Scandinavica, 1974
- Chronic beta adrenergic blockade in arterial hypertension: Hemodynamic influences of dihydralazine and dynamic exercise and clinical effects of combined treatmentThe American Journal of Cardiology, 1972
- Combined Therapy with Vasodilator Drugs and Beta-Adrenergic Blockade in HypertensionCirculation, 1972
- Pharmacological Properties of Hydrallazine, Dihydrallazine and Some Related CompoundsJournal of Pharmacy and Pharmacology, 1957
- Studies on the Control of Hypertension by HyphexCirculation, 1953
- The Hemodynamic Effects of Hypotensive Drugs in ManCirculation, 1953